+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Disease Modalities & Software Market by Imaging Modality, Software Type, Disease Indication, End User, Deployment Mode, Distribution Channel - Global Forecast to 2030- Product Image
Brain Disease Modalities & Software Market by Imaging Modality, Software Type, Disease Indication, End User, Deployment Mode, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Brain Disease Modalities & Software Market by Imaging Modality, Software Type, Disease Indication, End User, Deployment Mode, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011105
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brain Disease Modalities & Software Market shows promising growth, evolving from USD 16.11 billion in 2024 to USD 16.98 billion in 2025, and is projected to reach USD 21.86 billion by 2030.

Pioneering Progress in Brain Disease Modalities and Software

The realm of brain disease modalities and software is advancing remarkably through the synergy of innovation, clinical necessity, and technological sophistication. Neurological disorders present significant global health challenges, bridging the urgent need for enhanced diagnostic accuracy and therapeutic progress. Innovations in imaging technologies like computed tomography and MRI, alongside AI-powered software solutions, are transforming our approach to conditions such as Alzheimer’s and traumatic brain injuries.

Amidst these developments, stakeholders—ranging from manufacturers to healthcare providers—are navigating a landscape reshaped by regulatory transformations and supply-chain dynamics. This report offers a comprehensive analysis of these elements, providing the necessary insights for decisions that promote innovation, strategic investments, and improved patient outcomes.

Evolving Forces Redefining Diagnosis and Care

The diagnostic landscape for neurological diseases is undergoing transformative shifts. AI technologies are now integral to clinical practice, providing real-time image analysis and predictive insights. Hybrid imaging systems, like PET-MRI and spectral CT, offer unprecedented detail and precision in brain analysis.

Software advancements are equally significant, integrating diverse data such as EEG and patient records into cohesive decision support systems. These advancements streamline healthcare workflows, expediting diagnoses and enhancing care coordination, ultimately fostering a shift toward value-based care.

Key Takeaways from This Report

  • Emerging technologies in brain imaging and software are reshaping clinical practices.
  • Market stakeholders must leverage insights to enhance strategic planning and innovative investment.
  • AI and hybrid imaging are leading to more precise and effective brain disease management.
  • Regional dynamics significantly impact adoption rates and strategic alignment is crucial.

Assessing the 2025 Tariff Wave on Brain Disease Technologies

In 2025, new U.S. tariffs on imported components impact the brain disease technology sector. These tariffs elevate input costs for manufacturers and increase fees for software developers dependent on overseas resources. The financial pressures lead healthcare providers to reconsider procurement strategies, adjusting budget allocations to accommodate the heightened costs.

This tariff environment encourages companies to amplify R&D investments, aiming to counteract margin pressures through product diversification and regional partnerships. Strategic adjustments are crucial to navigate the complexities introduced by changing tariff policies.

Decoding Market Segmentation to Reveal Core Trends

Understanding market segmentation unveils vital opportunities within the brain disease modalities and software market. Conventional CT remains fundamental for structural analysis, whereas spectral CT boosts tissue characterization. Increasing demand for portable monitoring solutions is driven by advancements in ambulatory EEG.

The software domain is witnessing a shift with deep learning outpacing traditional algorithms in diagnostic accuracy. Clinical decision support tools are evolving into comprehensive solutions, streamlining healthcare pathways and reducing operational burdens for healthcare teams.

In disease indication, Alzheimer’s continues to dominate due to its prevalence, yet diverse needs across conditions like epilepsy, multiple sclerosis, and strokes drive the demand for advanced MRI and CT solutions.

Furthermore, end users such as ambulatory centers and hospitals exhibit varied adoption preferences, influenced by deployment mode efficiencies and distribution channel effectiveness, guiding product placement strategies.

Unveiling Regional Dynamics Shaping Market Growth

Regional characteristics significantly influence market direction. In the Americas, established healthcare systems and reimbursement frameworks drive the assimilation of sophisticated imaging tools and software. Conversely, Europe and emerging markets in the Middle East and Africa face unique challenges but present opportunities through partnerships and investments in health infrastructure.

Asia-Pacific emerges as a rapid growth area, propelled by government initiatives and increasing demand for digital health solutions. Countries like China and Japan are at the forefront of hardware and software innovation, expanding market potential through regional partnerships.

Competitive Landscape and Strategic Positioning Insights

Leading companies are advancing through technology integration, strategic alliances, and targeted acquisitions. Major players incorporate AI within diagnostic portfolios, enhancing performance and integration with existing healthcare systems.

Start-ups, focusing on specific high-impact areas, such as early dementia screening, are vital contributors to market innovation. The emergence of digital marketplaces and subscription models further enhance competitive dynamics, setting the stage for continued growth.

Strategic Imperatives for Industry Leadership

To succeed, industry leaders must prioritize AI integration across platforms and nurture collaborative ventures to validate innovative workflows. Diversifying supply chains and aligning solutions with regional regulations will bolster resilience amidst geopolitical challenges. Targeting high-growth disease areas and optimizing distribution networks can lead to strengthened market positions and sustainable innovation.

Robust Methodology Underpinning the Research Findings

This report employs a rigorous research methodology, blending secondary data with primary qualitative insights. Peer-reviewed literature, regulatory filings, and comprehensive expert interviews provide a robust foundation for market analysis. The research findings empower stakeholders with data-driven strategies essential for successful navigation of the evolving brain disease modalities and software market landscape.

In summary, the fusion of innovative technologies with strategic foresight positions firms to conquer the complexities of the brain disease market, driving advances in neurological care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brain Disease Modalities & Software Market, by Imaging Modality
8.1. Introduction
8.2. Computed Tomography
8.2.1. Conventional Ct
8.2.2. Spectral Ct
8.3. Electroencephalography
8.3.1. Ambulatory Eeg
8.3.2. Routine Eeg
8.4. Magnetic Resonance Imaging
8.4.1. Diffusion Tensor Imaging
8.4.2. Functional Mri
8.4.3. Structural Mri
8.5. Magnetoencephalography
8.5.1. Evoked Response
8.5.2. Resting State
8.6. Positron Emission Tomography
8.6.1. Amyloid Pet
8.6.2. Fdg Pet
8.7. Ultrasound
8.7.1. High Resolution
8.7.2. Transcranial Doppler
9. Brain Disease Modalities & Software Market, by Software Type
9.1. Introduction
9.2. Ai Based Software
9.2.1. Deep Learning Algorithms
9.2.2. Machine Learning Algorithms
9.3. Clinical Decision Support Software
9.4. Diagnostic Software
9.4.1. Image Analysis Software
9.4.2. Segmentation Software
9.5. Monitoring Software
9.5.1. Neurophysiological Monitoring
9.5.2. Remote Patient Monitoring
9.6. Telehealth Platform
9.7. Workflow Management Software
10. Brain Disease Modalities & Software Market, by Disease Indication
10.1. Introduction
10.2. Alzheimer's Disease
10.3. Epilepsy
10.3.1. Focal Onset
10.3.2. Generalized Onset
10.4. Multiple Sclerosis
10.5. Parkinson's Disease
10.6. Stroke
10.6.1. Hemorrhagic Stroke
10.6.2. Ischemic Stroke
10.7. Traumatic Brain Injury
10.7.1. Mild Tbi
10.7.2. Severe Tbi
11. Brain Disease Modalities & Software Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.3.1. Neurology Clinics
11.3.2. Rehabilitation Clinics
11.4. Diagnostic Imaging Centers
11.5. Hospitals
11.5.1. Private Hospitals
11.5.2. Public Hospitals
11.6. Research Institutes
12. Brain Disease Modalities & Software Market, by Deployment Mode
12.1. Introduction
12.2. Cloud Based
12.3. Hybrid
12.4. On Premise
13. Brain Disease Modalities & Software Market, by Distribution Channel
13.1. Introduction
13.2. Direct
13.3. Distributors
13.4. Online Platforms
14. Americas Brain Disease Modalities & Software Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Brain Disease Modalities & Software Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Brain Disease Modalities & Software Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Siemens Healthineers AG
17.3.2. GE HealthCare Technologies Inc.
17.3.3. Koninklijke Philips N.V.
17.3.4. Canon Medical Systems Corporation
17.3.5. Hitachi, Ltd.
17.3.6. Brainlab AG
17.3.7. Elekta AB (publ)
17.3.8. Medtronic plc
17.3.9. Stryker Corporation
17.3.10. IBM Corporation
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET MULTI-CURRENCY
FIGURE 2. BRAIN DISEASE MODALITIES & SOFTWARE MARKET MULTI-LANGUAGE
FIGURE 3. BRAIN DISEASE MODALITIES & SOFTWARE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ROUTINE EEG, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIFFUSION TENSOR IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FUNCTIONAL MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STRUCTURAL MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EVOKED RESPONSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESTING STATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMYLOID PET, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FDG PET, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HIGH RESOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRANSCRANIAL DOPPLER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEEP LEARNING ALGORITHMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICAL DECISION SUPPORT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEGMENTATION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROPHYSIOLOGICAL MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REMOTE PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TELEHEALTH PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY WORKFLOW MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY FOCAL ONSET, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY GENERALIZED ONSET, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HEMORRHAGIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MILD TBI, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SEVERE TBI, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEUROLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REHABILITATION CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLOUD BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIRECT, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 126. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 127. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 128. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 129. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 130. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 131. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 132. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 133. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 134. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 135. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 136. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 137. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 138. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 139. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 140. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 141. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 144. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 145. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 159. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 160. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 161. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 165. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 173. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 174. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 175. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 176. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 177. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 178. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 179. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 180. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 181. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 183. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 184. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 185. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 188. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 189. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 190. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 191. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 192. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 193. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 194. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 195. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 196. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 197. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 198. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 199. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 200. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 201. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 203. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 204. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 205. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 228. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 238. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 240. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 242. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 244. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 246. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 248. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 249. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 250. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 251. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 252. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 253. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 254. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 255. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 256. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 257. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 258. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 259. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 260. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 261. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 262. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 264. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 265. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2030 (USD MILLION)
TABLE 266. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IMAGING MODALITY, 2018-2030 (USD MILLION)
TABLE 268. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COMPUTED TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 269. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 270. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2030 (USD MILLION)
TABLE 271. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2030 (USD MILLION)
TABLE 272. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 273. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ULTRASOUND, 2018-2030 (USD MILLION)
TABLE 274. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY SOFTWARE TYPE, 2018-2030 (USD MILLION)
TABLE 275. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY AI BASED SOFTWARE, 2018-2030 (USD MILLION)
TABLE 276. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DIAGNOSTIC SOFTWARE, 2018-2030 (USD MILLION)
TABLE 277. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MONITORING SOFTWARE, 2018-2030 (USD MILLION)
TABLE 278. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 279. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 280. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 281. FRANCE BRAIN

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Brain Disease Modalities & Software market report include:
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Hitachi, Ltd.
  • Brainlab AG
  • Elekta AB (publ)
  • Medtronic plc
  • Stryker Corporation
  • IBM Corporation

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 16.98 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.86 Billion
Compound Annual Growth Rate5.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Medical Image Analysis Software Market by Deployment Mode, Component, End User, Imaging Modality, Application - Global Forecast to 2030 - Product Image

Medical Image Analysis Software Market by Deployment Mode, Component, End User, Imaging Modality, Application - Global Forecast to 2030

  • Report
  • 199 Pages
  • Global
From
Coronary Flow Reserve Fractional Calculation Software Market by Distribution Channel, Delivery Mode, End User, Application, Modality, Technology - Global Forecast to 2030 - Product Image

Coronary Flow Reserve Fractional Calculation Software Market by Distribution Channel, Delivery Mode, End User, Application, Modality, Technology - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029 - Product Image

Clinical Trial Imaging Market by Software & Service (Operational Imaging, Trial Design), Modality (CT, MRI, X-Ray, PET, Ultrasound), Therapeutic Area (Infectious, Oncology, CNS, CVD), End User (Pharma, Biotech, CROs) - Global Forecast to 2029

  • Report
  • 249 Pages
  • Global
From
Cattle Management Software Market Size, Share & Trends Analysis Report by Sector (Dairy, Meat), Software Type (Monitoring, Trading/ Marketing), End-use (Milk Harvesting Management, Health Management), Region, and Segment Forecasts, 2025-2030 - Product Image

Cattle Management Software Market Size, Share & Trends Analysis Report by Sector (Dairy, Meat), Software Type (Monitoring, Trading/ Marketing), End-use (Milk Harvesting Management, Health Management), Region, and Segment Forecasts, 2025-2030

  • Report
  • 200 Pages
  • Global
From
Medical Imaging Analysis Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Medical Imaging Analysis Software - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.